Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Entomed MedTech AB
AB
Dissolved
Org 5567916605
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2009 · 16 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Entomed MedTech AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
10M
7M
5M
2M
0M
2020: 5M
5M
2020
2021: 6M (+20% vs 2020)
6M
+20%
2021
2022: 7M (+17% vs 2021)
7M
+17%
2022
2023: 8M (+14% vs 2022)
8M
+14%
2023
2024: 6M (-25% vs 2023)
6M
-25%
2024
EBITDA
SEK millions
1M
1M
1M
0M
0M
2020: 1M
1M
2020
2021: 1M (0% vs 2020)
1M
0%
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
5 983
7 925
7 371
6 433
5 434
Staff expenses
−1 256
—
—
—
—
EBITDA
244
662
587
614
518
Depreciation & amort.
−57
−77
−91
−46
−31
EBIT
187
585
496
568
487
Net financials
14
7
—
−5
−2
Profit before tax
286
547
420
523
506
Tax
−67
−122
−100
−112
−110
Net profit
219
425
320
411
396
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
5 683
5 614
5 208
4 421
4 289
Equity
3 780
3 561
3 136
2 815
2 555
Long-term debt
—
0
0
0
0
Short-term debt
966
1 032
1 096
705
874
Total debt
966
1 032
1 096
705
874
Financial ratios
5-year trend
EBITDA margin
4,1 %
This company
15,8 %
Market median
This company
Market median
74% below market
2020
2024
Equity ratio
66,5 %
This company
38,2 %
Market median
This company
Market median
74% above market
2020
2024
Return on equity
5,8 %
This company
18,4 %
Market median
This company
Market median
68% below market
2020
2024
Net profit margin
3,7 %
This company
8,1 %
Market median
This company
Market median
54% below market
2020
2024
Asset turnover
1,05×
This company
1,12×
Market median
This company
Market median
6% below market
2020
2024
Debt / equity
0,50×
This company
0,62×
Market median
This company
Market median
19% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Entomed MedTech AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
